Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

STIRLING ANGLIAN PHARMACEUTICALS LIMITED

Company number SC453258

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Apr 2024 MR01 Registration of charge SC4532580003, created on 28 March 2024
08 Aug 2023 AA Accounts for a small company made up to 31 December 2022
06 Jul 2023 CS01 Confirmation statement made on 6 July 2023 with no updates
02 May 2023 AD02 Register inspection address has been changed from C/O Shepherd and Wedderburn Llp 1 Exchange Crescent Conference Square Edinburgh EH3 8UL United Kingdom to C/O Shepherd & Wedderburn Llp 9 Haymarket Square Edinburgh EH3 8FY
21 Feb 2023 AP01 Appointment of Mr Mark Charles Inker as a director on 20 February 2023
29 Sep 2022 AA Unaudited abridged accounts made up to 31 December 2021
05 Aug 2022 CS01 Confirmation statement made on 5 July 2022 with updates
19 Jan 2022 AD03 Register(s) moved to registered inspection location C/O Shepherd and Wedderburn Llp 1 Exchange Crescent Conference Square Edinburgh EH3 8UL
19 Jan 2022 AD02 Register inspection address has been changed to C/O Shepherd and Wedderburn Llp 1 Exchange Crescent Conference Square Edinburgh EH3 8UL
19 Jan 2022 MA Memorandum and Articles of Association
19 Jan 2022 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
05 Jan 2022 SH01 Statement of capital following an allotment of shares on 21 December 2021
  • GBP 0.020267
24 Dec 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
23 Dec 2021 AA01 Current accounting period extended from 25 December 2021 to 31 December 2021
23 Dec 2021 MR04 Satisfaction of charge SC4532580002 in full
22 Dec 2021 PSC02 Notification of Kelso International Limited as a person with significant control on 21 December 2021
22 Dec 2021 TM01 Termination of appointment of Sean Ambrose Perrie as a director on 21 December 2021
22 Dec 2021 TM01 Termination of appointment of Mark Cook as a director on 21 December 2021
22 Dec 2021 AP01 Appointment of Dr Harry Thomas Stratford as a director on 21 December 2021
22 Dec 2021 AP01 Appointment of Mr Allan Mark Watson as a director on 21 December 2021
22 Dec 2021 AP01 Appointment of Mr Andrew Firth Mclean as a director on 21 December 2021
22 Dec 2021 PSC07 Cessation of Sean Ambrose Perrie as a person with significant control on 21 December 2021
04 Aug 2021 MR04 Satisfaction of charge SC4532580001 in full
19 Jul 2021 CS01 Confirmation statement made on 5 July 2021 with no updates
09 Jun 2021 AA Unaudited abridged accounts made up to 31 December 2020